Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
53
FRPT Quote, Financials, Valuation and Earnings
Last price:
$145.17
Seasonality move
:
11.11%
Day range:
$140.67 - $143.79
52-week range:
$82.16 - $160.91
Dividend yield:
0%
P/E ratio:
161.54x
P/S ratio:
7.63x
P/B ratio:
6.83x
Volume:
471.3K
Avg. volume:
469.7K
1-year change:
68.59%
Market cap:
$7B
Revenue:
$766.9M
EPS (TTM):
$0.89
Analysts' Opinion
-
Consensus RatingFreshpet has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Freshpet has an estimated upside of 15.43% from its current price of $143.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $143.77.
Fair Value
-
According to the consensus of 0 analysts, Freshpet has 15.43% upside to fair value with a price target of -- per share.
FRPT vs. S&P 500
-
Over the past 5 trading days, Freshpet has underperformed the S&P 500 by -3.91% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Freshpet does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Freshpet has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Freshpet reported revenues of $253.4M.
Earnings Growth
-
Freshpet has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Freshpet reported earnings per share of $0.24.
Enterprise value:
7.1B
EV / Invested capital:
5.01x
Price / LTM sales:
7.63x
EV / EBIT:
125.77x
EV / Revenue:
7.65x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-108.55x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
58.29x
Gross Profit (TTM):
$358.9M
Return On Assets:
2.97%
Net Income Margin (TTM):
4.75%
Return On Equity:
4.51%
Return On Invested Capital:
3.22%
Operating Margin:
4.7%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $545.4M | $717.3M | $927.9M | $200.6M | $253.4M | |
| Gross Profit | $181.6M | $222M | $358.9M | $66.3M | $102.2M | |
| Operating Income | -$57.6M | -$47.4M | $33.5M | -$7.1M | $11.9M | |
| EBITDA | -$24.6M | $18.6M | $121.8M | $13.6M | $33.8M | |
| Diluted EPS | -$1.45 | -$1.08 | $0.89 | -$0.15 | $0.24 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $137.5M | $237.8M | $383.5M | $462.4M | $421.3M | |
| Total Assets | $425.9M | $758.3M | $1.2B | $1.4B | $1.5B | |
| Current Liabilities | $24M | $28.7M | $131M | $83.8M | $89.2M | |
| Total Liabilities | $31.5M | $34.8M | $135.6M | $505.8M | $510.3M | |
| Total Equity | $394.5M | $723.5M | $1B | $938.6M | $1B | |
| Total Debt | -- | -- | $72.9M | $392.6M | $394.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$49.7M | $49.4M | $140.9M | $39.2M | $56.1M | |
| Cash From Investing | -$291.8M | -$204.4M | -$206.3M | $54.3M | -$34M | |
| Cash From Financing | $411M | $252.8M | $1.9M | $554K | $828K | |
| Free Cash Flow | -$318.4M | -$174.9M | -$65.4M | -$19.9M | $22.1M | |
FRPT
Sector
Market Cap
$7B
$347.3M
Price % of 52-Week High
89.35%
73.63%
Dividend Yield
0%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
68.59%
-13.33%
Beta (5-Year)
1.412
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$144.46
200-day SMA
Buy
Level
$130.34
Bollinger Bands (100)
Buy
Level
132.04 - 150.02
Chaikin Money Flow
Buy
Level
16.6M
20-day SMA
Sell
Level
$149.59
Relative Strength Index (RSI14)
Sell
Level
41.14
ADX Line
Sell
Level
11.17
Williams %R
Neutral
Level
-78.0142
50-day SMA
Sell
Level
$146.99
MACD (12, 26)
Sell
Level
-1.76
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
22.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.3641)
Buy
CA Score
(Annual)
Level (0.93)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.3416)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. The former two store types accounted for 89% of 2023 sales, with grocery stores representing the primary driver of footprint growth. Freshpet primarily targets dogs (92% of sales), with cats and treats comprising the rest of its sales. Geographically, the company’s home US market, where all its food is produced, accounts for about 96% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.
Stock Forecast FAQ
In the current month, FRPT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FRPT average analyst price target in the past 3 months is --.
-
Where Will Freshpet Stock Be In 1 Year?
According to analysts, the consensus estimate is that Freshpet share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Freshpet?
Analysts are divided on their view about Freshpet share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Freshpet is a Sell and believe this share price will drop from its current level to --.
-
What Is Freshpet's Price Target?
The price target for Freshpet over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FRPT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Freshpet is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of FRPT?
You can purchase shares of Freshpet via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Freshpet shares.
-
What Is The Freshpet Share Price Today?
Freshpet was last trading at $145.17 per share. This represents the most recent stock quote for Freshpet. Yesterday, Freshpet closed at $143.77 per share.
-
How To Buy Freshpet Stock Online?
In order to purchase Freshpet stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 19.74% over the past day.
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.12% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.82% over the past day.
